Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 1325 (113th)

Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2013

referredUnited States· United States Congress· EN

Introduced

21 March 2013

Last action

10 April 2013 · Referred

Status

Referred to the Subcommittee on Health.

Sponsors

Rep. Burgess, Michael C. [R-TX-26], Sen. Blackburn, Marsha [R-TN], Rep. Marino, Tom [R-PA-10], Sen. Cassidy, Bill [R-LA], Rep. Young, C. W. Bill [R-FL-13], Rep. Crenshaw, Ander [R-FL-4], Rep. McDermott, Jim [D-WA-7], Rep. Bachus, Spencer [R-AL-6], Rep. Grimm, Michael G. [R-NY-11], Rep. Wolf, Frank R. [R-VA-10], Rep. Tiberi, Patrick J. [R-OH-12], Rep. Kind, Ron [D-WI-3], Rep. Cooper, Jim [D-TN-5], Rep. Himes, James A. [D-CT-4], Rep. Loebsack, David [D-IA-2], Rep. Capps, Lois [D-CA-24]

Subjects

Healthcare

Source updated

6 December 2025

Healthcare

Official sourceDownload fileView documentsShare

Summary

Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2013 - Amends title II (Old Age, Survivors and Disability Benefits) (OASDI) of the Social Security Act (SSA) to extend the months of coverage of immunosuppressive drugs for kidney transplant patients. Amends SSA title XVIII (Medicare) to make eligible for enrollment in Medicare part B (Supplementary Medical Insurance), solely for the purpose of such drug coverage, every individual whose insurance benefits under Medicare part A (Hospital Insurance) have ended by reason of a kidney transplant or the end of any requirement for a regular course of dialysis. Directs the Secretary of Health and Human Services (HHS) to determine a monthly premium rate for such individuals equal to 35% of the monthly actuarial rate for enrollees age 65 and over. Prescribes a formula for detemination of a government contribution to such a premium.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 21 March 2013

    Introduced

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Source: IntroReferral

  2. 21 March 2013

    Introduced

    Introduced in House

    Source: IntroReferral

  3. 21 March 2013

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 22 March 2013

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

  5. 10 April 2013

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House (text)

    Introduced in House · EN · 21 March 2013

    ViewDownloadOpen at official source

  • Introduced in House (PDF)

    Introduced in House · EN · 21 March 2013

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House

    summary · EN · 21 March 2013

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Related records

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.